Status | Study |
Recruiting |
Study Name: The Leigh Syndrome Registry Condition: Leigh Syndrome Leigh Disease Leigh's Necrotizing Encephalo Date: 2017-04-28 |
Not yet recruiting |
Study Name: Safety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers Condition: MELAS Syndrome Mitochondrial Respiratory Chain Deficiencies Date: 2017-02-05 Interventions: Drug: KL1333 25 mg oral admini |
Recruiting |
Study Name: The KHENERGY Study Condition: Mitochondrial Diseases Mitochondrial Myopathies Mitochondr Date: 2016-09-13 Interventions: Drug: KH176 Drug: placebo |
Recruiting |
Study Name: MNGIE Allogeneic Hematopoietic Stem Cell Transplant Safety Study Condition: Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE) Date: 2015-02-10 Interventions: Biological: Hematopoietic Allogeneic Stem Cells HLA 10/10 matched allogeneic bone marrow cells will be i |
Recruiting |
Study Name: MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis Condition: Mucopolysaccharidosis Disorders Hurler Syndrome Hunter Syn Date: 2014-06-20 Interventions: Biological: Stem Cell Transplantation |
Completed |
Study Name: Mitochondrial nt3243 A>G Mutation in Taiwan Condition: MELAS Syndrome Noninsulin-dependent Diabetes Mellitus With Deafness Date: 2014-02-09 |
Completed |
Study Name: Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease Condition: Inherited Mitochondrial Disease, Including Leigh Syndrome Date: 2013-12-17 Interventions: Drug: Cysteamine Bitartrate Cysteamine Bitartrate Delayed-release Capsules |
Completed |
Study Name: Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS) Condition: MELAS Syndrome Date: 2013-03-19 Interventions: Biological: Fluzone® This vaccine is given intramuscularly, either the 2010-2011 or 2011-2012 vacci |
Recruiting |
Study Name: North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) Condition: Mitochondrial Disorders Mitochondrial Genetic Disorders Mi Date: 2012-09-25 |
Completed |
Study Name: L-arginine Therapy on Endothelium-dependent Vasodilation & Mitochondrial Metabolism in MELAS Syndrome Condition: MELAS Syndrome Date: 2012-05-18 Interventions: Drug: L-Arginine NOW® L-Arginine powder |